Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis - PubMed (original) (raw)
Clinical Trial
Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis
B M Winklhofer-Roob et al. Free Radic Biol Med. 1995 May.
Abstract
We investigated the effect of correcting beta-carotene deficiency in cystic fibrosis (CF) patients on two parameters of lipid peroxidation. The resistance to oxidation of low density lipoprotein (LDL) was measured by the lag time preceding the onset of conjugated diene formation during exposure to copper(II) ions, and lipid peroxide formation was quantitated by malondialdehyde concentrations in plasma (TBA/HPLC method). Simultaneously, alpha-tocopherol and beta-carotene concentrations were determined in LDL and in plasma. Thirty-four CF patients were investigated before and after 3 months of oral beta-carotene supplementation. Beta-carotene concentrations increased (p < 0.0001) in plasma (mean +/- SD) (0.09 +/- 0.06 vs. 1.07 +/- 0.86 mumol/l) and in LDL (0.02 +/- 0.02 vs. 0.31 +/- 0.28 mol/mol), without significant changes in alpha-tocopherol, either in plasma (24.7 +/- 5.9 vs. 25.4 +/- 7.6) or in LDL (8.47 +/- 2.95 vs. 9.05 +/- 4.13). Lag times, being shorter (p < 0.05) in patients than in controls, increased from 48.5 +/- 21.3 to 69.1 +/- 27.9 min (p < 0.001) and plasma MDA concentrations, being greater (p < 0.0001) in patients than in controls, decreased from 0.95 +/- 0.32 to 0.61 +/- 0.15 mumol/l (p < 0.0001). At 3 months, lag times and MDA concentrations did not any longer differ between patients and controls. These data suggest that excess lipid peroxidation occurring in beta-carotene deficiency can be limited and normalized during efficient beta-carotene supplementation in CF patients.
Similar articles
- Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation.
Meraji S, Ziouzenkova O, Resch U, Khoschsorur A, Tatzber F, Esterbauer H. Meraji S, et al. Eur J Clin Nutr. 1997 May;51(5):318-25. doi: 10.1038/sj.ejcn.1600405. Eur J Clin Nutr. 1997. PMID: 9152683 Clinical Trial. - Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation.
Winklhofer-Roob BM, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Müller G, van't Hof MA, Esterbauer H, Shmerling DH. Winklhofer-Roob BM, et al. Free Radic Biol Med. 1995 Dec;19(6):725-33. doi: 10.1016/0891-5849(95)00063-4. Free Radic Biol Med. 1995. PMID: 8582644 - Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
Rust P, Eichler I, Renner S, Elmadfa I. Rust P, et al. Int J Vitam Nutr Res. 1998;68(2):83-7. Int J Vitam Nutr Res. 1998. PMID: 9565821 Clinical Trial. - Optimal nutrition: vitamin E.
Morrissey PA, Sheehy PJ. Morrissey PA, et al. Proc Nutr Soc. 1999 May;58(2):459-68. doi: 10.1017/s0029665199000609. Proc Nutr Soc. 1999. PMID: 10466191 Review. - Plant carotenoids and related molecules: important dietary antioxidants.
Krinsky NI. Krinsky NI. Biochem Soc Symp. 1995;61:117-26. doi: 10.1042/bss0610117. Biochem Soc Symp. 1995. PMID: 8660389 Review.
Cited by
- Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
Hurley MN, Smith S, Forrester DL, Smyth AR. Hurley MN, et al. Cochrane Database Syst Rev. 2020 Jul 16;7(7):CD008037. doi: 10.1002/14651858.CD008037.pub4. Cochrane Database Syst Rev. 2020. PMID: 32671834 Free PMC article. - Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.
Causer AJ, Shute JK, Cummings MH, Shepherd AI, Gruet M, Costello JT, Bailey S, Lindley M, Pearson C, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL. Causer AJ, et al. Redox Biol. 2020 May;32:101436. doi: 10.1016/j.redox.2020.101436. Epub 2020 Jan 23. Redox Biol. 2020. PMID: 32044291 Free PMC article. Review. - Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O, Smith S, Lykkesfeldt J. Ciofu O, et al. Cochrane Database Syst Rev. 2019 Oct 3;10(10):CD007020. doi: 10.1002/14651858.CD007020.pub4. Cochrane Database Syst Rev. 2019. PMID: 31580490 Free PMC article. Review. - Carotenoids and Markers of Oxidative Stress in Human Observational Studies and Intervention Trials: Implications for Chronic Diseases.
Bohn T. Bohn T. Antioxidants (Basel). 2019 Jun 17;8(6):179. doi: 10.3390/antiox8060179. Antioxidants (Basel). 2019. PMID: 31213029 Free PMC article. Review. - The Effect of Lutein on Eye and Extra-Eye Health.
Buscemi S, Corleo D, Di Pace F, Petroni ML, Satriano A, Marchesini G. Buscemi S, et al. Nutrients. 2018 Sep 18;10(9):1321. doi: 10.3390/nu10091321. Nutrients. 2018. PMID: 30231532 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical